13 February 2015 : Case report
Ketamine and Propofol Combination (“Ketofol”) for Endotracheal Intubations in Critically Ill Patients: A Case Series
Unusual or unexpected effect of treatment, Unexpected drug reaction , Educational Purpose (only if useful for a systematic review or synthesis)Alice Gallo de MoraesABCDEFG, Carlos J. Racedo AfricanoABCDEFG, Sumedh S. HoskoteABCDEFG, Dereddi Raja S. ReddyADEF, Rudy TedjaABCDEFG, Lokendra ThakurADEF, Jasleen K. PannuABDE, Elizabeth C. HassebroekABDE, Nathan J. SmischneyABCDEFG
Am J Case Rep 2015; 16:81-86
BACKGROUND: Endotracheal intubation is a common procedure performed for critically ill patients that can have immediate life-threatening complications. Induction medications are routinely given to facilitate the procedure, but most of these medications are associated with hypotension. While etomidate is known for its neutral hemodynamic profile, it has been linked with increased mortality in septic patients and increased morbidity in trauma patients. Ketamine and propofol are effective anesthetics with counteracting cardiovascular profiles. No data are available about the use of this combination in critically ill patients undergoing endotracheal intubation.
CASE REPORT: We describe 6 cases in which the combination of ketamine and propofol (“ketofol”) was used as an induction agent for endotracheal intubation in critically ill patients with a focus on hemodynamic outcomes. All patients received a neuromuscular blocker and fentanyl, while 5 patients received midazolam. We recorded mean arterial pressure (MAP) 1 minute before induction and 15 minutes after intubation with the combination. Of the 6 patients, 5 maintained a MAP ≥65 mmHg 15 minutes after intubation. One patient was on norepinephrine infusion with a MAP of 64 mmHg, and did not require an increase in the dose of the vasopressor 15 minutes after intubation. No hemodynamic complications were reported after any of the intubations.
CONCLUSIONS: This case series describes the use of the “ketofol” combination as an induction agent for intubation in critically ill patients when hemodynamic stability is desired. Further research is needed to establish the safety of this combination and how it compares to other induction medications.
Keywords: Anesthetics, Dissociative - administration & dosage, Anesthetics, Intravenous - administration & dosage, Critical Illness - therapy, Drug Therapy, Combination, Intubation, Intratracheal - methods, Ketamine - administration & dosage, Pain Management - methods, Propofol - administration & dosage
26 November 2021 : EditorialEditorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
Med Sci Monit In Press; DOI: 10.12659/MSM.935624
26 November 2021 : Case reportArteritic Anterior Ischemic Optic Neuropathy in the Course of Giant Cell Arteritis After COVID-19
Am J Case Rep In Press; DOI: 10.12659/AJCR.933471
26 October 2021 : Case reportProgressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report
Am J Case Rep In Press; DOI: 10.12659/AJCR.933458
30 Nov 2021 : Case reportSevere Anion Gap Metabolic Acidosis Resulting from Combined Chronic Acetaminophen Toxicity and Starvation K...
Am J Case Rep In Press; DOI: 10.12659/AJCR.934410
30 Nov 2021 : Case reportGiant Fibroepithelial Polyps of the Vulva in a Woman with Uterine Myoma and Primary Infertility: A Case Rep...
Am J Case Rep In Press; DOI: 10.12659/AJCR.933198
29 Nov 2021 : Case reportSuccessful Management of Radiation-Associated Insufficiency Fracture of the Tibial Plateau with Low-Intensi...
Am J Case Rep In Press; DOI: 10.12659/AJCR.934372
Most Viewed Current Articles
15 Aug 2020 : Case reportA 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodul...
Am J Case Rep 2020; 21:e926779
09 May 2019 : Case reportA Rare Case of Stage IV Basaloid Squamous Cell Cancer with Intrapulmonary and Brain Metastases
Am J Case Rep 2019; 20:664-667
13 Mar 2019 : Case reportDry Beriberi Due to Thiamine Deficiency Associated with Peripheral Neuropathy and Wernicke’s Encephalopathy...
Am J Case Rep 2019; 20:330-334